SetPoint Medical is an early stage medical device company developing the Immune System Regulator – the first implantable neurostimulation device for the treatment of inflammation.

The Company’s platform technology is based on co-founder Dr. Kevin Tracey’s breakthrough discovery of the Inflammatory Reflex – the mechanism by which the central nervous system exerts direct control over the immune system.

Immune System Regulator therapy selectively stimulates the Inflammatory Reflex, dampening inflammation in autoimmune and other inflammation mediated diseases, providing a compelling therapeutic alternative to costly pharmaceuticals.